• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
LI Yichen, SHI Chuanlin, DING Xuansheng. 17β-Estradiol and fulvestrant inhibit glomerular mesangial cell fibrogenesis downstream of protein kinase C activation[J]. Journal of China Pharmaceutical University, 2017, 48(2): 208-213. DOI: 10.11665/j.issn.1000-5048.20170212
Citation: LI Yichen, SHI Chuanlin, DING Xuansheng. 17β-Estradiol and fulvestrant inhibit glomerular mesangial cell fibrogenesis downstream of protein kinase C activation[J]. Journal of China Pharmaceutical University, 2017, 48(2): 208-213. DOI: 10.11665/j.issn.1000-5048.20170212
shu

17β-Estradiol and fulvestrant inhibit glomerular mesangial cell fibrogenesis downstream of protein kinase C activation

More Information
    Graphical Abstract
    • Abstract
  • To investigate the effect of estrogen receptor(ER)agonist 17β-estradiol and G protein-coupled estrogen receptor 1(GPER)agonist fulvestrant on masangial cell fibrogenesis under protein kinase C(PKC), we quantified type IV collagen(COL4A1), fibronectin(FN1), connective tissue growth factor(CTGF)and transforming growth factor-β1(TGFβ1)gene transcription and semi-quantified phosphorylation of Akt signal upon Phorbol 12-myristate 13-acetate stimulation(which increased COL4A1, FN1, CTGF and TGFβ1 gene transcription to 2. 5±0. 5, 1. 4±0. 2, 26±11 and 1. 9±0. 3 times compared with baseline, P< 0. 05)when incubated with the two drugs. It was found that 17β-estradiol and fulvestrant down-regulated COL4A1, FN1, CTGF and TGFβ1 genes transcription(P< 0. 05)and Akt signaling under PKC activation via ER and GPER. ER and GPER agonists are beneficial in protecting the mesangial cells from fibrogenic stimuli by inhibiting PKC signaling and excessive extracellular matrix production.
    • FullText(HTML)
    • References (12)
  • [1]
    Wu D,Peng F,Zhang B,et al.PKC-β1 mediates glucose-induced Akt activation and TGF-β1 upregulation in mesangial cells[J].J Am Soc Nephrol,2009,20(3):554-566.
    [2]
    Abboud HE.Mesangial cell biology[J].Exp Cell Res,2012,318(9):979-985.
    [3]
    Silbiger S,Neugarten J.Gender and human chronic renal disease[J].Gender Med,2008,5(Suppl A):S3-S10.
    [4]
    Krepinsky J,Ingram AJ,James L,et al.17β-Estradiol modulates mechanical strain-induced MAPK activation in mesangial cells[J].J Biol Chem,2002,277(11):9387-9394.
    [5]
    Mankhey RW, Bhatti F, Maric C. 17β-Estradiol replacement improves renal function and pathology associated with diabetic nephropathy[J].Am J Physiol Renal Physiol,2005,288(2):F399-F405.
    [6]
    Fliardo EJ,Quinn JA,Frackelton Jr.AR,et al.Estrogen action via the G protein-coupled receptor,GPR30:stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis[J].Mol Endocrinol,2002,16(1):70-84.
    [7]
    Li YC,Ding XS,Li HM,et al.Role of G protein-coupled estrogen receptor 1 in modulating transforming growth factor-β stimulated mesangial cell extracellular matrix synthesis and migration[J].Mol Cell Endocrinol,2014,391(1/2):50-59.
    [8]
    Li YC, Ding XS, Li HM, et al. Icariin attenuates high glucose-induced type IV collagen and fibronectin accumulation in glomerular mesangial cells by inhibiting transforming growth factor-β production and signalling through G protein-coupled oestrogen receptor 1[J].Clin Exp Pharmacol Physiol,2013,40(9):635-643.
    [9]
    Kapor-Drezgic J,Zhou X,Babazono T,et al.Effect of high glucose on mesangial cell protein kinase C-δ and -ε is polyol pathway-dependent[J].J Am Soc Nephrol,1999,10(6):1193-1203.
    [10]
    Qu YK,Li X,Chen T,et al.Effects of fulvestrant on the estrogen receptor expression in uterus and vagina of immature mice[J].J China Pharm Univ(中国药科大学学报),2016,47(2):210-214.
    [11]
    Sraer JD,Delarue F,Hagege J,et al.Stable cell lines of T-SV40 immortalized human glomerular mesangial cells[J].Kidney Int,1996,49(1):267-270.
    [12]
    Biederman J,Yee J,Cortes P.Validation of internal control genes for gene expression analysis in diabetic glomerulosclerosis[J].Kidney Int,2004,66(6):2308-2314.
    • Related Articles

  • Related Articles

    [1]ZHOU Yongmei, TANG Cheng, ZHANG Sifang. Isolation and identification of antitumor constituents from Trichosanthes tricuspidata[J]. Journal of China Pharmaceutical University, 2019, 50(1): 46-52. DOI: 10.11665/j.issn.1000-5048.20190106
    [2]YE Feng, LYU Qinglin, ZHU Wanfang, FENG Feng, ZHANG Jie. Chemical constituents from the leaves of Anisopus mannii and the melanogenesis inhibitory activities[J]. Journal of China Pharmaceutical University, 2018, 49(6): 676-681. DOI: 10.11665/j.issn.1000-5048.20180606
    [3]ZHOU Yongmei, SHI Xianming, MA Lei, ZHANG Sifang. Isolation and identification of Withaphysalins from Physalis minima[J]. Journal of China Pharmaceutical University, 2015, 46(1): 62-65. DOI: 10.11665/j.issn.1000-5048.20150107
    [4]WANG Guoyan, ZHU Jingjing, LOU Fengchang. Chemical constituents from the exopleura of Ginkgo biloba and inhibition test of total ginkgolic acids against phytopathogenic fungi[J]. Journal of China Pharmaceutical University, 2014, 45(2): 170-174. DOI: 10.11665/j.issn.1000-5048.20140207
    [5]YIN Minmin, YIN Zhiqi, ZHANG Jian, WANG Lei, YE Wencai. Chemical constituents from ethyl acetate extract of Cynanchum otophyllum Schneid.[J]. Journal of China Pharmaceutical University, 2013, 44(3): 213-218. DOI: 10.11665/j.issn.1000-5048.20130305
    [6]LIU Zhi-yong, NIU Zhi-yuan, ZHENG Wei, SHEN Ping-ping. Effects of p-ERK1/2 on nitric oxide donor induced apoptosis of HepG2 cells[J]. Journal of China Pharmaceutical University, 2012, 43(6): 530-534.
    [7]RAO Ya-kun, DING Li, YU Yong. Structural identification of two major impurities in sodium levofolinate[J]. Journal of China Pharmaceutical University, 2012, 43(4): 350-354.
    [8]Study on the Chemical Constituents from the Leaves of Desmos chinensis Lour[J]. Journal of China Pharmaceutical University, 2003, (6): 22-24.
    [9]Effects of E6, a Calmodulin Antagonist, on Nitric Oxide Synthase in Rat''''s Brain and [3H]-Glutamic Acid Release from Synaptosome[J]. Journal of China Pharmaceutical University, 2002, (5): 81-85.
    [10]Advances in the Research of Nitric Oxide and Its Modulators[J]. Journal of China Pharmaceutical University, 2001, (5): 3-10.

  • Cited by

    Periodical cited type(0)

    Other cited types(1)

Catalog

    Get Citation
    PDF
    XML
    Article views (850) PDF downloads (2130) Cited by(1)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：300499

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return